Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Clinical Outcome
804 results:

  • 1. Spreading Through Air Spaces And Thinking About Lung Metastases.
    M Castro P; Rei J; Silva C; Miranda J; Guerra M
    Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [clinical outcome of Five Patients with Perforated colorectal cancer].
    Jinushi K; Ikenaga M; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Kawase T; Shimizu J; Imamura H; Dono K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1566-1568. PubMed ID: 38303343
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transanal minimally invasive surgery for benign and malignant rectal lesions: midterm outcomes from a tertiary center.
    Al-Dhaheri M; Al-Ishaq F; Toffaha A; Nada MA; Parvaiz A; Kurer M
    Ann Saudi Med; 2023; 43(6):348-351. PubMed ID: 38071443
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase angle as a prognostic indicator of surgical outcomes in patients with gastrointestinal cancer.
    Gulin J; Ipavic E; Mastnak DM; Brecelj E; Edhemovic I; Kozjek NR
    Radiol Oncol; 2023 Dec; 57(4):524-529. PubMed ID: 38038415
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
    Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
    Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
    Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
    Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Delayed-Onset Organ/Space Surgical Site Infection Worsens Prognosis in High-Risk Stage II and III colorectal cancer.
    Okui J; Shigeta K; Kato Y; Mizuno S; Sugiura K; Seo Y; Nakadai J; Baba H; Kikuchi H; Hirata A; Makino A; Kondo T; Matsui S; Seishima R; Okabayashi K; Obara H; Sato Y; Kitagawa Y
    J Gastrointest Surg; 2023 Nov; 27(11):2515-2525. PubMed ID: 37740145
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
    Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
    Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immune Marker Spatial Distribution and clinical outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced colorectal Carcinomas.
    Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
    Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mesenchymal Stem Cells and Regenerative Therapy with Bilateral Gracilis Flaps for Perineal Reconstruction of a Wound Infection in the Setting of Anal Squamous Cell Carcinoma.
    Garcia MF; Tiwari KK; Gendreau JL; Burgess PL; Taupin P; Martin ED
    Adv Skin Wound Care; 2023 Aug; 36(8):1-7. PubMed ID: 37471451
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Technique, sedation, and clinical outcome of endoscopic submucosal dissection for rectal tumor with involvement of dentate line: A retrospective cohort study.
    Noh YK; Lee J; Kim SJ
    Saudi J Gastroenterol; 2023; 29(6):365-370. PubMed ID: 37282445
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of ALCAM in clinical Colon cancer and Relationship With Patients' Treatment Responses.
    Fang Z; Zeng JJ; Yang Y; Ruge F; Lane J; Hargest R; Jiang WG
    In Vivo; 2023; 37(3):1117-1128. PubMed ID: 37103072
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effects of systemic inflammation and frailty on survival in elderly cancer patients: Results from the INSCOC study.
    Zhang Q; Wang Z; Song M; Liu T; Ding J; Deng L; Zhang X; Qian L; Ge Y; Xie H; Ruan G; Song C; Yao Q; Xu H; Ju H; Shi H
    Front Immunol; 2023; 14():936904. PubMed ID: 36891320
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials.
    Diefenhardt M; Fleischmann M; Martin D; Hofheinz RD; Piso P; Germer CT; Hambsch P; Grützmann R; Kirste S; Schlenska-Lange A; Ghadimi M; Rödel C; Fokas E;
    Radiother Oncol; 2023 Feb; 179():109455. PubMed ID: 36572280
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer.
    Paszt A; Ottlakan A; Abraham S; Simonka Z; Vas M; Maraz A; Szepes Z; Tiszlavicz L; Nyari T; Olah J; Lazar G
    Pathol Oncol Res; 2022; 28():1610722. PubMed ID: 36567978
    [No Abstract]    [Full Text] [Related]  

  • 19. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
    Jin Y; Deng J; Luo B; Zhong Y; Yu S
    Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
    [TBL] [Abstract] [Full Text] [Related]  


    of 41.